The Bayesian Modeling of Covariates for Population Pharmacokinetic Models

Journal of the American Statistical Association

Volumn 91, Issue 435, 1996, Pages 917-927

  Wakefield, Jon ^a   Bennett, James ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Clinical significance; Covariate selection; Dosage determination; Markov chain Monte Carlo; Prior information

Indexed keywords

EID: 0030327432     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1080/01621459.1996.10476961     Document Type: Article

References (25)

1. Boeckman, A. J., Sheiner, L. B., and Beal, S. L. (1993), NONMEM User's Guide Version IV, San Francisco: University of California Press.
2. Chipman, H. (1995), “Bayesian Variable Selection With Related Predictors,” in press.
3. Davidian, M., and Giltinan, D. M. (1995), Nonlinear Models for Repeated Measures Data, London: Chapman and Hall.
4. Del Mar Fernandez De Gatta, M., Fruns, I., and Dommguez-Gil, A. (1994), “Individualizing Vancomycin Dosing Regimens: An Evaluation of Two Pharmacokinetic Dosing Programs in Critically 111 Patients,” Pharmacotherapy, 14, 196-201.
5. Draper, D. (1995), “Assessment and Propagation of Model Uncertainty” (with discussion), Journal of the Royal Statistical Society, Ser. B, 57, 45-97.
6. Garthwaite, P. H., and Dickey, J. M. (1992), “Elicitation of Prior Distributions for Variable-Selection Problems in Regression,” The Annals of Statistics, 20, 1697-1719.
7. George, E. I., and McCulloch, R. E. (1993), “Variable Selection via Gibbs Sampling,” Journal of the American Statistical Association, 88, 881-889.
8. George, E. I., and McCulloch, R. E. (1995), “Fast Variable Selection via Stochastic Simulation,” in Markov Chain Monte Carlo in Practice, eds. W. R. Gilks, S. Richardson, and D. Spiegelhalter, London: Chapman and Hall, pp. 203-214.
9. Gibaldi, M., and Perrier, D. (1982), Drugs and the Pharmaceutical Sciences, Volume 15, Pharmacokinetics (2nd ed.), New York: Marcel Dekker.
10. Green, P. J. (1995), “Reversible Jump Markov Chain Monte Carlo Computation and Bayesian Model Determination,” Biometrika, 82, 711-732.
11. Holford, N. H. G., and Sheiner, L. B. (1981), “Kinetics of Pharmacological Response,” Pharmacology and Therapeutics, 16, 143-166.
12. Laud, P. W., and Ibrahim, J. G. (1995), “Predictive Model Selection,” Journal of the Royal Statistical Society, Ser. B, 57, 247-262.
13. Lindley, D. V. (1968), “The Choice of Variables in Multiple Regression,” Journal of the Royal Statistical Society, Ser. B, 30, 31-53.
14. Madigan, D., and Raftery, A. E. (1994), “Model Selection and Accounting for Model Uncertainty in Graphical Models Using Occam’s Window,” Journal of the American Statistical Association, 89, 1535-1546.
15. Maitre, P. O., Buhrer, M., Thomson, D., and Stanski, D. (1991), “A Three-Step Approach to Combining Bayesian Regression and NONMEM Population Analysis,” Journal of Pharmacokinetics and Biopharmaceutics, 19, 377-384.
16. Miller, A. J. (1990), Subset Selection in Regression, London: Chapman and Hall.
17. Mitchell, T. J., and Beauchamp, J. J. (1988), “Bayesian Variable Selection in Linear Regression,” Journal of the American Statistical Association, 83, 1023-1036.
18. Phillips, D. B., and Smith, A. F. M. (1995), “Bayesian Model Comparison via Jump Diffusions,” in Markov Chain Monte Carlo in Practice, eds. W. R. Gilks, S. Richardson, and D. Spiegelhalter, London: Chapman and Hall, pp. 215-239.
19. Smith, A. F. M., and Roberts, G. O. (1993), “Bayesian Computation via the Gibbs Sampler and Related Markov Chain Monte Carlo,” Journal of the Royal Statistical Society, Ser. B, 55, 39-52.
20. Steimer, J.-L., Vozeh, S., Racine-Poon, A., Holford, N. G., and O’Neill, R. (1994), ‘The Population Approach: Rationale, Methods and Applications in Clinical Pharmacology and Drug Development,” in Handbook of Experimental Pharmacology, Volume 110, Pharmacokinetics of Drugs, eds. P. Welling and H. Balant, New York: Springer-Verlag.
21. Tierney, L. (1994), “Markov Chains for Exploring Posterior Distributions,” The Annals of Statistics, 22, 1701-1762.
22. Wakefield, J. C. (1994), “An Accepted Loss Approach to the Design of Dosage Regimens Via Sampling-Based Methods,” The Statistician, 43, 13-29.
23. Wakefield, J. C. (1996), “The Bayesian Analysis of Population Pharmacokinetic Models,” Journal of the American Statistical Association, 91, 62-75.
24. Wakefield, J. C., and Racine-Poon, A. (1995), “An Application of Bayesian Population Pharmacokinetic/Pharmacodynamic Models to Dose Recommendation,” Statistics in Medicine, 14, 971-986.
25. Wakefield, J. C., Smith, A. F. M., Racine-Poon, A., and Gelfand, A. E. (1994), “Bayesian Analysis of Linear and Nonlinear Population Models Using the Gibbs Sampler,” Applied Statistics, 43, 201-221.